ReviewNeurology and therapy2024

The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson's Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On.

Pekka T Männistö et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.